Severe Graves' disease-associated orbitopathy: A rare case of frontal bone hemangioma

Ahmad Alamri; Daphné Pauchet; André Balaton; Constance Oriez; Olivier Dupuy; Adrien Ben Hamou

doi:10.1002/ccr3.3638

Severe Graves' disease-associated orbitopathy: A rare case of frontal bone hemangioma

Clin Case Rep. 2020 Dec 10;9(2):787-789. doi: 10.1002/ccr3.3638. eCollection 2021 Feb.

Authors

Ahmad Alamri^{1

2}, Daphné Pauchet^{1

2}, André Balaton^{1

2}, Constance Oriez^{1

2}, Olivier Dupuy^{1

2}, Adrien Ben Hamou^{1

2

3}

Affiliations

¹ Paris Saint Joseph Hospital Group Paris France.
² Diabetology, Endocrinology and Nutrition Paris France.
³ Thyroid Unit, American Hospital of Paris Neuilly-sur-Seine France.

Abstract

Graves' orbitopathy might be severe, requiring treatment with high-dose glucocorticoids. A lytic bone lesion, malignant lesions, and diseases resulting from bone remodeling processes (eg, Paget's disease) must be excluded by markers and imagery. Outcomes of high-dose glucocorticoids and thyrotoxicosis must be screened and prevented.

Keywords: Graves’ disease‐associated orbitopathy; frontal bone hemangioma; intravenous glucocorticoids.

Publication types

Case Reports